C3is (NASDAQ:CISS) Raised to “Sell” at Wall Street Zen

C3is (NASDAQ:CISSGet Free Report) was upgraded by investment analysts at Wall Street Zen to a “sell” rating in a note issued to investors on Saturday.

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of C3is in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, C3is currently has an average rating of “Sell”.

Get Our Latest Analysis on C3is

C3is Price Performance

Shares of NASDAQ CISS opened at $1.85 on Friday. The company has a 50 day simple moving average of $8.60 and a 200-day simple moving average of $34.90. The company has a market capitalization of $1.89 million, a P/E ratio of -0.01 and a beta of 1.96. C3is has a 1 year low of $1.35 and a 1 year high of $151.20.

Institutional Investors Weigh In On C3is

An institutional investor recently bought a new position in C3is stock. Citadel Advisors LLC bought a new position in shares of C3is Inc. (NASDAQ:CISSFree Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 13,221 shares of the company’s stock, valued at approximately $29,000. Citadel Advisors LLC owned approximately 0.74% of C3is at the end of the most recent quarter. Institutional investors and hedge funds own 10.54% of the company’s stock.

About C3is

(Get Free Report)

C3is Inc offers international seaborne transportation services. It provides its services to dry bulk charterers, including national and private industrial users, commodity producers and traders, oil producers, refineries, and commodities traders and producers. The company owns and operates a fleet of two drybulk carriers, which transport major bulks, such as iron ore, coal and grains, as well as minor bulks comprising bauxite, phosphate, and fertilizers, and one Aframax crude oil tanker that transports crude oil.

See Also

Receive News & Ratings for C3is Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for C3is and related companies with MarketBeat.com's FREE daily email newsletter.